The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
WW announced on Thursday that it will be laying off employees and cutting costs to the tune of $100 million per year.
Blue Origin is going slower than SpaceX, but it also nailed a massive rocket launch on the first try. Jeff Bezos is back in the space race.
The listing marks a potentially triumphant comeback story and an insult of sorts to the embattled London stock exchange.
With the way things are going today, it’s becoming increasingly hard to figure out what’s going on with the oil market.